Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;457(2):389-404.
doi: 10.1007/s00424-008-0532-3. Epub 2008 Jun 7.

Vasomotion has chloride-dependency in rat mesenteric small arteries

Affiliations

Vasomotion has chloride-dependency in rat mesenteric small arteries

D M Briggs Boedtkjer et al. Pflugers Arch. 2008 Nov.

Abstract

The possibility that Ca(2+)-activated Cl(-) conductances (CaCCs) contribute to oscillations in vascular tone (vasomotion) is tested in isolated mesenteric small arteries from rats where cGMP independent (I (Cl(Ca))) and cGMP-dependent (I (Cl(Ca,cGMP))) chloride conductances are important. The effect of anion substitution and Cl(-) channel blockers on noradrenaline (NA)-stimulated tension in isometrically mounted mesenteric arteries and for chloride conductance of smooth muscle cells isolated from these arteries were assessed electrophysiologically. Cl(-) (o) replacement with aspartate blocked vasomotion while 36mM SCN(-) (o) (substituted for Cl(-)) was sufficient to inhibit vasomotion. Oscillations in tone, membrane potential, and [Ca(2+)](i) disappeared with 36mM SCN(-). DIDS and Zn(2+) blocked I (Cl(Ca,cGMP)) but not I (Cl(Ca)). Vasomotion was not sensitive to DIDS and Zn(2+), and DIDS and Zn(2+) induce vasomotion in arteries without endothelium. The vasomotion in the presence of DIDS and Zn(2+) was sensitive to 36mM SCN(-) (o). The anion substitution data indicate that Cl(-) is crucial for the V (m) and [Ca(2+)](i) oscillations underlying vasomotion. The Cl(-) channel blocker data are consistent with both CaCCs being important.

PubMed Disclaimer

References

    1. J Physiol. 2001 Jul 15;534(Pt. 2):395-408 - PubMed
    1. Physiol Rev. 1999 Jan;79(1 Suppl):S47-75 - PubMed
    1. Circ Res. 2001 Apr 27;88(8):810-5 - PubMed
    1. J Physiol. 1997 Aug 15;503 ( Pt 1):99-110 - PubMed
    1. Br J Pharmacol. 2004 Jul;142(6):961-72 - PubMed

Publication types

MeSH terms

LinkOut - more resources